Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Qiagen NV launches QuantiFERON-TB Gold In-Tube in China


Thursday, 20 Mar 2014 02:56am EDT 

Qiagen NV:Commercial launch in China of QuantiFERON-TB Gold In-Tube (QuantiFERON-TB), pioneering blood test that accurately identifies people infected with Mycobacterium tuberculosis, bacterium that causes tuberculosis (TB).QuantiFERON-TB has become test of choice around world and is displacing century-old tuberculin skin test (TST) in screening for TB infection.QIAGEN already sells QuantiFERON-TB in many markets, including U.S. and Europe, and gained approval earlier this year from China Food and Drug Administration (CFDA).QIAGEN announced the QuantiFERON-TB launch to coincide with World TB Day 2014, March 24. 

Company Quote

24.99
0.11 +0.44%
25 Jul 2014